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Abstract
Background: Many cardiac patients need and undergo device implants. Veterans’ preferences 
regarding  post-mortem handling  of  devices  are  not  known.  Cardiac  patients  in  low-  and 
middle-income countries who need but cannot afford devices rely on donations. Charitable 
organizations have successfully provided devices for reuse to such patients.                  
Objective: We estimated the number of devices with potential for possible reuse in a veteran 
population.  
Methods:  Between January and December 2008, at a tertiary medical center, veterans with 
implanted cardiac devices were surveyed using a questionnaire for their preferences regarding 
post-mortem handling. One choice was donation to charity for reuse. Although altruistic, it is 
unclear  what  percent  of  such devices  have  reuse  potential.  Retrospective  chart  review of 
veterans  who  underwent  device  implants  between  1992  and  2007  identified  a  cohort  of 
patients with Implantable Cardiac Defibrillators (ICDs) who had died by April 31st 2009. In 
this cohort, ICDs implanted in the year preceding the patient’s death were counted as having 
reuse  potential.                                         
Results:  94 of 97 veterans  completed the survey. 56% were unaware of how devices  are 
handled  after  death.  The  top  three  preferences  for  postmortem  handling  were:  return  to 
manufacturer, return to hospital and donation for reuse. 88% were willing to sign an advance 
device directive. Retrospective review identified 161 veterans who had received 301 ICDs. Of 
these, 77 ICDs (25%) had median reuse potential of 3.1 years.                               
Conclusion: In a VA cohort of deceased patients a substantial proportion of devices had reuse 
potential.  Further research is needed to direct health policy.                               
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Introduction
Sudden cardiac  death  (SCD) and heart  failure  utilize  significant  health  care  resources.[1] 
Device therapy for SCD and heart failure [2-6] have decreased mortality and patients tend to 
live  longer.[7]  While  the  number  of  Implantable  Cardioverter  Defibrillator  (ICD) 
implantations in the US has increased, [8] global inequalities in health care access result in 
low device  utilization  rates  in  low- and middle-income countries  [9]  despite  the growing 
burden  of  cardiovascular  disease.                                          
Charitable  organizations  have  been  providing  devices,  generously  donated  by  industry  or 
harvested by physicians,  to patients in low- and middle-income countries.[10,11] Recently 
published studies have shown that there is no increase in morbidity or mortality associated 
with device  reuse [19].  Large  scale  clinical  studies  of  device  reutilization  in  underserved 
countries have been suggested [12] but the availability of devices with potential for reuse is 
unknown.
In a survey, 10% of responding electrophysiologists had harvested devices for purposes of 
donation [13].  The HRS guidelines  recommend that  physicians  seek patients’  consent  for 
post-mortem device retrieval while they are alive.[14] In routine practice, informed consent 
for device implants rarely includes a discussion regarding post-mortem handling of devices. A 
survey of patient preferences showed that 87% of 150 patients did not know how devices 
were handled after their death. The majority were willing to have their devices retrieved for 
return  to  the  manufacturer  or  for  reuse.[15]                                           
Patient  preferences  for  post-mortem  handling  affect  health  policy.  We  studied  these 
preferences  in  a  veteran  population.  We  also  estimated  the  availability  of  devices  with 
potential for reuse in another veteran cohort from the same institution. Such data affect the 
feasibility  of  larger  scale  clinical  studies.                                         
Methods
The  first  protocol  for  patient  preferences  consisted  of  a  confidential  close  ended  survey 
administered  to  a  sample  of  patients  with  cardiac  implanted  devices  (implantable  cardiac 
defibrillators) who attend the device clinic at the Louis Stokes Cleveland Department of VA 
Medical  Center  (LSCDVAMC).  The  survey  was  a  structured  questionnaire  of  patient 
preferences regarding post-mortem handling of devices. The survey was based on the prior 
work of Kirkpatrick et al [15] and Wild et al [16]. The questionnaire was provided to patients 
consenting  to  participate  in  the  survey.  After  their  clinic  visit,  patients  independently 
completed the survey, sometimes with help from their caregiver. The investigator answered 
additional questions after completion of the survey to minimize biasing patients’ choices. The 
questionnaire  did  not  collect  any  patient  identifiers.                                 
Data collected  included age,  height,  weight,  type  of  device,  years  since  their  first  device 
implant and the number of device implants. The survey asked patients if they had a living 
will, health care proxy or designated power of attorney followed by their idea of how devices 
were  handled  after  their  death.  Patients  then  ranked  8  possible  choices  for  post-mortem 
handling of devices including donation for reuse (Table 1). They were asked if they were 
willing to sign a directive regarding their choices for postmortem handling.
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Table 1: Patient preferences for post-mortem handling of devices
A second protocol was used to estimate the number of ICDs with potential for reuse. Some of 
the data from this protocol has been published [17]. The charts of all patients who underwent 
device  implants  at  LSCDVAMC  between  June  1992  and  April  2007  were  reviewed. 
Information  regarding  the  device,  procedure,  complications,  follow-up  and  subsequent 
procedures  was  obtained.  The  Social  Security  death  index  and  the  charts  were  used  to 
identify a cohort of these patients who were no longer alive as of April 31st 2009. Detailed 
device interrogation data was not available for many of these patients.                        
In this cohort, two sets of devices were identified. The first set consisted of all ICD/CRT-Ds 
that were replaced for battery depletion alone over the life of the patients.  From this set, 
“actual longevity” was derived. The “actual longevity” was defined as the number of days the 
devices had lasted before replacement for normal battery depletion. For each device this was 
calculated as the number of days from Date of Implant  to Date of Replacement.         
The second set consisted of the ICD/CRT-Ds in the patient at the time of their death. From 
this set,  devices  with “reuse potential”  were identified.  These were devices that  had been 
implanted within 1 year preceding the patients’ death. For these devices with reuse potential,  
“utilized longevity” was calculated as the number of days from Date of Implant to Date of 
Death. The “magnitude of reuse potential” was defined as the difference between the Median 
“actual longevity” of all devices replaced for normal battery depletion (set 1) and the Median 
“utilized  longevity”  (set  2).                                                    
Since we used the median duration that devices lasted in the first set and the median duration 
of device use in the second set, we feel that this method of measuring the “magnitude of reuse 
potential” is a valid measure of expected remaining battery longevity.  The protocols were 
approved  by  the  IRB.                                              
Statistical  Methods                                       
The  data  were  tabulated  in  Microsoft  Excel  and  analyzed  using  SPSS  15.0.  Descriptive 
statistics are reported for the survey. BMI was dichotomized into >/= 25.0 and < 25.0 kg/m². 
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Results
Of 97 patients who were asked to participate in the survey, 94 patients completed the survey 
for a response rate of 97%. One patient filled out part of the survey. Two additional patients  
refused. The mean age was 67.7 years. Only two patients were younger than 50 years. There 
was a single female in this group. The median Body Mass Index (BMI) was 30.5. Sixty nine 
(73.4%) patients  were overweight or obese.  The majority  of patients  had undergone their 
implant more than a year ago. The currently active device was the first for 74 patients. The 
type of device distribution is shown in Table 2.
Table 2. Device characteristics
 
Survey  Results                                              
Disposition after death: The majority (53 patients or 56.4%) of patients did not have any idea 
of what happened to their device post mortem. 16, 12 and 10 patients respectively believed 
that the device was sent back to the company, buried with them, or reused/recycled while 3 
patients thought it would be donated to charity.                                           
Preferences for Post mortem Handling: Seventy two patients (76.5%) chose at least one of the 
listed options for post mortem handling of their device and rank ordered their preferences. 
One interesting observation was that no one wanted to be buried with their device including 
the twelve patients who thought that would be the case. Every patient except one, expressed 
strong feelings about not wanting the device to be buried with them.                         
The majority  of patients  (61.7% or 58 patients)  had a living will,  health  care proxy or a 
durable health care power of attorney. In this group, 83 patients (88%) were willing to state 
their preferences for post-mortem handling of their device in writing in the form of a device 
directive.
Identifying  ICDs  with  “reuse  potential”                                       
A total of 379 patients underwent 646 ICD/CRT-D device implants, between August 1992 
and April  2007.  Of  these,  161 patients  had  died  by  April  2009.  These  161 patients  had 
received a total of 301 ICD implants of which 147 ICDs were replaced for normal battery 
depletion in 61 patients. These 147 ICDs with normal battery depletion were replaced after a 
median of 1295 days (median “actual longevity”). Among the patients who died, there were 
77 devices  that  had  been implanted  less  than  a  year  prior  to  the  patient’s  death  (median 
“utilized  longevity” 161 days).  This  gives an estimated  magnitude of “reuse potential”  of 
1134 days for the 77 devices. The cause of death was unrelated to the ICD implant procedure. 
These 77 devices with median “reuse potential” of 3.1 years constituted 25.6% of the ICDs in 
this cohort. Additionally in 3 patients, ICDs were replaced within a month due to high DFTs 
and 2 other patients were upgraded to CRT-Ds within 6 months of ICD implant.  These 5 
devices  if  included  would  result  in  82  devices  with  significant  reuse  potential.
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Discussion
Patient  preferences                                                
Very few patients have any idea of the way devices are handled post mortem. This finding is 
similar to that of Kirkpatrick et al.[15] The vast majority of patients (99%) in this survey did 
not want to be buried with their  device.  The top 3 patients’  preferences were donation to 
charity, return to the manufacturer, and return to the hospital. This is aligned with the Heart 
Rhythm  Society  task  force  guidelines  which  strongly  encourages  postmortem  device 
interrogation, explantation and return to the manufacturer particularly in cases of sudden or 
unexpected  death.[14]                                     
Return  of  retrieved  devices  to  manufacturers  or  hospitals  would  increase  the  number  of 
devices available for post mortem returned product analysis. Bartsch C et al have shown that 
there is much undetected device dysfunction in their post mortem analysis of 415 pacemakers 
(and ICD) by in-situ and bench tests. Their postmortem evaluated rate of dysfunction in the 
life-threatening category of 3.8% and premature exhaustion of battery of 1.2% corresponded 
to an annual complication rate of 0.94%. The annual ICD malfunction replacement rate was 
significantly higher than the pacemaker malfunction replacement rate (mean [SD], 20.7 [11.6] 
vs. 4.6 [2.2] replacements per 1000 implants.[18]                                         
In our survey, 44.6% of patients wished to donate their devices for post mortem reuse as their  
first choice and 79% chose this among their top three options. 88% were willing to sign a 
device directive.  In the survey of Kirkpatrick et al 91% of patients chose this  option.[15]
Practical  limitations  for  this  preference  include  communicating  this  preference  to  the 
mortician and sending the explanted device to an organization that can test the device for 
useful battery life, test for normal function, clean/sterilize it and then send it to an appropriate 
institution for implantation in a deserving recipient in a country where it is considered legal 
and  ethical.                                           
Reuse  potential  of  explanted  devices                                            
The analysis of the VA database showed that 25.6% of all devices implanted in the deceased 
cohort had potentially useful remaining battery life. If reused in economically disadvantaged 
individuals  in  low-  and  middle-  income  countries  with  an  ICD  indication  for  secondary 
prevention of SCD, the median reuse potential of 1134 days (3.3 years) is the duration for 
which 77 patients would receive some protection from SCD.                                
At least 25% of these patients will receive appropriate therapy over a year based on the results 
of trials of secondary prevention. This is in concordance with a recently published study from 
India, in which explanted ICDs with at least 3 years of remaining battery life were safely 
reused  after  careful  cleaning  and  resterilization.  These  ICDs  functioned  appropriately  in 
delivering life-saving therapies without an increased risk of complications.[19]             
Reuse  of  devices  poses  risks  such  as  infection,  device  malfunction  or  premature  battery 
depletion. In Sweden pacemakers had been successfully reused in the 1990s for several years. 
In one retrospective study, 100 patients who received reused pacemakers were compared to 
100 patients who received a new pacemaker and followed for a mean of 32 +/- 11 months. 
There were no early replacements due to battery depletion in either of the groups and a cost 
benefit analysis showed cost savings. Reuse without increased risk was feasible as long as 
proper technical control and sterilization protocols were followed.[20]                       
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Baman et al have shown that it is possible to successfully harvest devices with remaining 
useful battery life and reuse them in patients in low- to middle- income countries. In their 
study, 18 of 50 donated pacemakers from Detroit metropolitan area funeral homes to World 
Medical Relief had 70% battery life. 12 patients in the Philippines underwent implantation 
and suffered no complications over a 2- month follow up period.[21]                                  
Hasan et al published a case series of 17 Nicaraguan patients with a Class 1 indication for a 
Cardiac  Implantable  Device  who received  devices  that  were harvested ante  mortem from 
patients at a single US institution. During the long term follow up of 68 +/- 38 months, there 
were no infections,  device  malfunction  or  premature  battery  depletion.  One patient  had a 
hematoma at the time of implant.[22] A meta-analysis of over 600 patients in 4 clinical trials 
did not show any evidence of increased infection risk with reused pacemakers compared to 
new implants.[23] These data suggest that a significant proportion of devices may have the 
potential for reuse. It may be reasonable to support larger studies to better address these risks.
The incidence of cardiovascular disease is projected to increase by 137% between 1990 and 
2020 in Low- and Middle- Income countries while financial constraints continue to increase 
the disparity in health services between industrialized nations and Low- and Middle- income 
countries, especially in the field of devices.[24] Device re-utilization may be an option for 
such  patients.  Considerable  organization  and  collaboration  between  hospital  systems  in 
different countries, funeral homes and charitable organizations is necessary for such reuse. 
Organizations such as World Medical Relief [11] have protocols to reuse explanted devices 
and  have  provided  donated  pacemakers  for  reuse  successfully  although  there  are  several 
logistical,  ethical  and  legal  barriers.[25,26]  An  initiative  to  reuse  devices  to  alleviate 
symptomatic bradyarrhythmia in low- and middle- income countries has been proposed.[27]
Incorporating patient preferences has significant implications for patient safety, health policy, 
health  care  economics  and the device  industry.                                         
Limitations
This is a small sample confined to a specific patient population in one geographic region and 
may not be applicable to other populations. The data regarding the number of devices with 
potentially usable battery life was derived from a retrospective analysis of patients’ whose 
devices and battery technology are different from currently used devices; recent generation 
devices show longer battery life, and therefore may offer greater reuse potential. This study 
also does not take into account any patient factors and actual remaining battery power was not 
measured.  The  majority  of  patients  in  this  cohort  had  a  secondary  indication  for  ICD 
placement.  These  reasons  would  affect  the  magnitude  of  “reuse  potential”  although  the 
methodology used here is more likely to have underestimated remaining device longevity. 
A study  utilizing  large  datasets  maintained  by  device  manufacturers  in  conjunction  with 
multiple  academic  institutions  may  give  a  better  estimate  of  number  of  devices  with 
significant reuse potential. Further research is needed to direct policy.                                  
Conclusion
Most patients are unaware of how devices are handled after their death. A majority of patients 
would  express  their  preference  in  the  form of  a  written  directive.  Patient  preferences  are 
aligned with the Heart Rhythm Society’s recommendations for morticians to harvest devices 
and return it to the manufacturer for device testing. Patients are willing to donate their devices 
for other uses after their death. A significant proportion of devices at the time of death may 
have  potential  for  reuse.                                                
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